Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 168.70 EUR | +2.87% |
|
-9.21% | -19.71% |
| 06:57am | SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating | ZD |
| 12:20am | Sartorius Stedim Biotech S.A., H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 15.96B 18.14B 14.82B 13.63B 25.57B 1,757B 26.03B 177B 69.14B 857B 68.11B 66.64B 2,973B | P/E 2026 * |
42.9x | P/E 2027 * | 32.4x |
|---|---|---|---|---|---|
| Enterprise Value | 17.97B 20.43B 16.69B 15.35B 28.79B 1,978B 29.31B 200B 77.85B 965B 76.69B 75.04B 3,348B | EV / Sales 2026 * |
5.74x | EV / Sales 2027 * | 5.09x |
| Free-Float |
28.47% | Yield 2026 * |
0.5% | Yield 2027 * | 0.63% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +2.80% | ||
| 1 week | -9.21% | ||
| Current month | -7.16% | ||
| 1 month | -0.35% | ||
| 3 months | +3.88% | ||
| 6 months | -19.25% | ||
| Current year | -19.71% |
| 1 week | 158.9 |  | 187.4 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 287.8 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.87% | -9.21% | -3.79% | -38.22% | 18.14B | |
| +0.18% | +1.94% | -19.93% | -11.85% | 175B | |
| +0.15% | -1.85% | -10.87% | -7.81% | 105B | |
| +1.49% | -0.95% | +3.96% | +58.40% | 59.35B | |
| -1.13% | -2.60% | +26.37% | +54.76% | 50.71B | |
| -0.12% | -4.35% | -16.22% | -42.24% | 42.15B | |
| +1.21% | -8.47% | - | - | 31.82B | |
| -1.33% | -9.62% | -18.45% | -46.03% | 27.2B | |
| -0.82% | -1.92% | +56.39% | -5.79% | 25.11B | |
| +0.03% | -4.74% | -6.58% | -9.24% | 20.53B | |
| Average | +0.29% | -4.33% | +1.21% | -5.34% | 55.55B | |
| Weighted average by Cap. | +0.28% | -1.87% | -5.80% | -1.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.56B 2.91B 2.67B 5.02B 345B 5.11B 34.78B 13.57B 168B 13.36B 13.07B 583B | 3.48B 3.96B 3.23B 2.97B 5.58B 383B 5.68B 38.67B 15.08B 187B 14.86B 14.54B 649B |
| Net income | 369M 420M 343M 316M 592M 40.67B 602M 4.1B 1.6B 19.84B 1.58B 1.54B 68.81B | 482M 548M 448M 412M 772M 53.07B 786M 5.35B 2.09B 25.88B 2.06B 2.01B 89.8B |
| Net Debt | 2.01B 2.29B 1.87B 1.72B 3.22B 221B 3.28B 22.33B 8.71B 108B 8.58B 8.4B 375B | 1.77B 2.01B 1.64B 1.51B 2.83B 195B 2.88B 19.63B 7.66B 94.91B 7.54B 7.38B 329B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | €168.70 | +2.87% | 34,524 |
| 26-07-23 | €164.00 | -6.45% | 215,014 |
| 26-07-22 | €175.30 | +5.22% | 134,439 |
| 26-07-21 | €166.60 | -7.55% | 213,161 |
| 26-07-20 | €180.20 | -2.96% | 55,079 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
